Accelerating and commercializing
advanced biotechnologies to
match the needs of our
newly globalized world
with a regenerative specialization.
The ability to accelerate unique products and partnerships is proven by the track record of the
ATVC team. Leading a group of research, commercialization, manufacturing, brand, and marketing experts, founder Michael Crowley has personally launched, and successfully commercialized 20+ advanced technology businesses.
OUR REPUTATION:
TO DATE ATVC HAS COMMERCIALIZED THE FOLLOWING EARLY STAGE BIOTECH VENTURES:
Techtrepreneurship
Certificate Course
REGENERELLE™
At Regenerelle, we are experts in radically simplifying the use of adult human mesenchymal stem/stromal cells (hMSCs) to propel the commercialization of therapeutic technologies. By enabling living cells to become more affordable at the lowest cost per million cells with industry leading quality, we make MSCs easier to access and much simpler to incorporate into product development efforts, leading to rapid acceleration in products coming to market that incorporate these technologies.
SANATELA PRECISION CANCER™
Cancer is a stem cell disease. This precision medicine technology is a lab developed test that determines how your cancer stem cells respond to chemotherapy before you undergo treatment.
RESILIÉLLE™
Topical Use Only Cosmetic Exosomes are entering into the cosmeceutical industry at lightning speed. RESILIÉLLE topical use only exosomes are manufactured and tested by 3rd party independent US Certified CLIA labs. Age Zero hMSC-EXOs are an ideal rejuvenation topical exosome product for plastic surgeons, dermatologists, aestheticians and regenerative clinicians seeking a revitalizing topical solution after microneedling or other skin abrasion treatments.
SANATELA ANIMAL HEALTH™
Veterinarians are learning more and more in applying our technical knowledge and regenerative knowledge to care for animals.
SANATELA REGENETIVE
MEDICAL SOLUTIONS™
Our R&D is built on a foundation of innovative development and efficient production of regenerative dressings that heal skin (wounds and burns) and bone fractures. SRMS’s Wharton’s jelly scaffold encourages the body to bio-attract stem cells to the point of injury to promote healing without scarring, usually within 3 weeks.
HARRAGAN™
Harragan is a company focused on commercializing innovative research leading to the development of high-value products for large-market opportunities. Our clinical strengths are in addressing hair regeneration.
SANATELA BIOTECHNOLOGIES™
SANATELA LIFE SCIENCES™
COMING SOON
PARTNERSHIPS
Cornell University
Rochester Institute of Technology
Kansas State University
Start-Up New York
Expand your cell and stem cell culture experience with Sanatella Matrix, a natural extracellular matrix. It is shelf stable, requires no thawing, and is room temperature stable. Our product produces excellent lot-to-lot consistency. We are ready to ship it immediately for 3D culture assays. It is a natural, ready-to-use Human Wharton’s jelly Bio-based product, not animal-based.
University of Rochester
University of Rochester
Stem Cell & Regenerative
Medicine Institute
University of Rochester
Wilmont Cancer Center
Monroe County
Empire State Development Corporation
TECHTREPRENEURSHIP™
We use our uniquely targeted educational perspective to work with and train prospective technology entrepreneurs, (we call our Certified Trainees “Techtrepreneurs™”), teaching them to work together in perfect rhythm and tear down the “silos” that exist within the technical entrepreneurship ecosystem
REGISTER FOR A SESSION IN COMMERCIALIZATION AND
ENTREPRENEURIAL
METHODS TO THE LEFT
OUR TEAM AND MESSAGE
Michael Crowley
Co-Founder & CEO
It is our belief through the advancement of truly advanced technology, we can positively effect GDP growth in participating markets, on a regional to global scale. If we educate business, research, and academic leaders on how to commercialize their advanced research more effectively, we can make a measured and impressive impact on our world.
AFFORDABLE
AFFORDABLE
AFFORDABLE
AFFORDABLE
AFFORDABLE
AFFORDABLEAFFORDABLEAFFORDABLEAFFORDABLEAFFORDABLEAFFORDABLEAFFORDABLEAFFORDABLEAFFORDABLEAFFORDABLEAFFORDABLEAFFORDABLEAFFORDABLEAFFORDABLEAFFORDABLEAFFORDABLEAFFORDABLEAFFORDABLEAFFORDABLE
ACCESSIBLE
ACCESSIBLE
ACCESSIBLE
ACCESSIBLE
ACCESSIBLE
ACCESSIBLEACCESSIBLEACCESSIBLEACCESSIBLEACCESSIBLEACCESSIBLEACCESSIBLEACCESSIBLEACCESSIBLEACCESSIBLEACCESSIBLEACCESSIBLEACCESSIBLEACCESSIBLEACCESSIBLEACCESSIBLEACCESSIBLEACCESSIBLEACCESSIBLE
ADVANCED
ADVANCED
ADVANCED
ADVANCED
ADVANCED
ADVANCED
ADVANCED
ADVANCED
ADVANCED
ADVANCED
ADVANCED
ADVANCED
ADVANCED
ADVANCED
ADVANCED
ADVANCED
ADVANCED
ADVANCED
ADVANCED
ADVANCED
ADVANCED
ADVANCED
ADVANCED
ADVANCED
AFFORDABLE
AFFORDABLE
AFFORDABLE
AFFORDABLE
AFFORDABLE
AFFORDABLEAFFORDABLEAFFORDABLEAFFORDABLEAFFORDABLEAFFORDABLEAFFORDABLEAFFORDABLEAFFORDABLEAFFORDABLEAFFORDABLEAFFORDABLEAFFORDABLEAFFORDABLEAFFORDABLEAFFORDABLEAFFORDABLEAFFORDABLEAFFORDABLE
ACCESSIBLE
ACCESSIBLE
ACCESSIBLE
ACCESSIBLE
ACCESSIBLE
ACCESSIBLEACCESSIBLEACCESSIBLEACCESSIBLEACCESSIBLEACCESSIBLEACCESSIBLEACCESSIBLEACCESSIBLEACCESSIBLEACCESSIBLEACCESSIBLEACCESSIBLEACCESSIBLEACCESSIBLEACCESSIBLEACCESSIBLEACCESSIBLEACCESSIBLE
ADVANCED
ADVANCED
ADVANCED
ADVANCED
ADVANCED
ADVANCED
ADVANCED
ADVANCED
ADVANCED
ADVANCED
ADVANCED
ADVANCED
ADVANCED
ADVANCED
ADVANCED
ADVANCED
ADVANCED
ADVANCED
ADVANCED
ADVANCED
ADVANCED
ADVANCED
ADVANCED
ADVANCED
AFFORDABLE
AFFORDABLE
AFFORDABLE
AFFORDABLE
AFFORDABLE
AFFORDABLEAFFORDABLEAFFORDABLEAFFORDABLEAFFORDABLEAFFORDABLEAFFORDABLEAFFORDABLEAFFORDABLEAFFORDABLEAFFORDABLEAFFORDABLEAFFORDABLEAFFORDABLEAFFORDABLEAFFORDABLEAFFORDABLEAFFORDABLEAFFORDABLE
For any general inquiries, please fill in the following contact form:
CONTACT:
RETURN TO THE BEGINNING